Cargando…

The Use of Ivermectin in the Treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Shukla, Ajay Kumar, Misra, Saurav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974046/ https://www.ncbi.nlm.nih.gov/pubmed/36854869 http://dx.doi.org/10.1007/s11606-023-08104-8

Ejemplares similares

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Clinical inertia in elderly for vaccination
por: Shukla, Ajay Kumar, et al.
Publicado: (2021)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023)

A five-day course of ivermectin may reduce the duration of COVID-19 illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

The Effect of Ivermectin on Cases of COVID-19()
por: Annie, Frank H., et al.
Publicado: (2022)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
por: Popp, Maria, et al.
Publicado: (2022)

The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
por: Onyeaka, Helen, et al.
Publicado: (2022)

N95 respirator and surgical mask in the pandemic of COVID-19
por: Sureka, Binit, et al.
Publicado: (2020)

Aerosol containment device for use on suspected COVID-19 patients
por: Singh, Baljit, et al.
Publicado: (2020)

Holistic approach to patient care in COVID-19: Need of an hour
por: Kumar, Rohit, et al.
Publicado: (2020)

Super-spreader resurgence in COVID-19: Past encounters and future repercussion
por: Kumar, Deepak, et al.
Publicado: (2020)

Madhya Pradesh sickle cell mission: An initiative for screening, counseling and treatment of sickle cell disorders among tribal communities
por: Bijlwan, Aanchal, et al.
Publicado: (2022)

Use of electronic logbook in psychiatry training and its relevance during COVID-19 pandemic in India
por: Kumar, Ajay, et al.
Publicado: (2021)

On diagnostic accuracy of COVID-19
por: Gupta, Harish, et al.
Publicado: (2022)

Methemoglobinemia in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2021)

Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021)

COVID-19 updates
por: Gupta, Harish, et al.
Publicado: (2022)

Ivermectin as a potential treatment for COVID-19?
por: Chosidow, Olivier, et al.
Publicado: (2021)

Use of ivermectin in the treatment of Covid-19: A pilot trial
por: Pott-Junior, Henrique, et al.
Publicado: (2021)

Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic
por: Becker, Nora V., et al.
Publicado: (2023)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Fight COVID-19 depression with immunity booster: Curcumin for psychoneuroimmunomodulation
por: Soni, Vivek Kumar, et al.
Publicado: (2020)

Recovery from Covid-19 may be prolonged
por: Gupta, Harish, et al.
Publicado: (2021)

Comment on “Attitude, practice, behavior, and mental health impact of COVID-19 on doctors”
por: Somani, Aditya, et al.
Publicado: (2020)

Mental health status of ophthalmology residents during COVID-19 pandemic—A national online survey
por: Parija, Sucheta, et al.
Publicado: (2023)

Migrants and Health Status: Assessing Adherence to Treatment in Noncommunicable Diseases is Important
por: Basu, Saurav
Publicado: (2019)

Mechanisms of stroke and the role of anticoagulants in COVID-19
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Cardiovascular factors predicting poor outcome in COVID-19 patients
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jimb10e013emsgd5ovk389lfsc